Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer
Pola Olczak, Ken Matsui, Margaret Wong, et al.
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 16

Showing 16 citing articles:

Unveiling the Therapeutic Horizon: HPV Vaccines and Their Impact on Cutaneous Diseases—A Comprehensive Review
Florica Șandru, Andreea-Maria Radu, Aida Petca, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 228-228
Open Access | Times Cited: 9
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell–like Program Conserved in HPV-Positive Cancers
Lukas Leiendecker, Tobias Neumann, Pauline S. Jung, et al.
Cancer Discovery (2022) Vol. 13, Iss. 1, pp. 70-84
Open Access | Times Cited: 36
HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage
Gaia Giannone, Anna R. Giuliano, Marco Bandini, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102467-102467
Closed Access | Times Cited: 34
Improving the efficacy of peptide vaccines in cancer immunotherapy
Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110721-110721
Closed Access | Times Cited: 16
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis
Margaret Wong, Hsin-Fang Tu, S.‐Ja Tseng, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012837-e1012837
Open Access
The h4 coil surface region of human papillomavirus type 58 L1 virus-like particle serves as a potential location for presenting the RG1 epitope peptide
Zhirong Wang, Ting Zhang, Xuemei Xu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
Melinda Ahmels, Filipe Colaço Mariz, Ilona Braspenning‐Wesch, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Prevention and Treatment of HPV-Induced Skin Tumors
Daniel Hasche, Baki Akgül
Cancers (2023) Vol. 15, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 7
Study on the clinical characteristics, persistent infection capability and viral load of human papillomavirus type 26 single infection
Zuyi Chen, Xiaoyang Li, Di Tian, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Deficiency in Ever2 does not increase susceptibility of mice to pathogenesis by the mouse papillomavirus, MmuPV1
Alexandra D. Torres, Renee E. King, Aayushi Uberoi, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Closed Access | Times Cited: 1
Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus
Nancy M. Cladel, Jie Xu, Xuwen Peng, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1964-1964
Open Access | Times Cited: 6
Factors Associated with HPV Knowledge Among Professionals in the City of Francisco Beltrão, Brazil
Adriane V. Grigolo, Guilherme Welter Wendt, Léia Carolina Lúcio
Journal of Community Health (2023) Vol. 48, Iss. 4, pp. 652-658
Closed Access | Times Cited: 2
Digital Papillary Adenocarcinoma Is HPV-42-Associated and BRAFV600E Negative: Perspectives for Diagnostic Practice
Tassilo Dege, Arno Rütten, Matthias Goebeler, et al.
Dermatopathology (2024) Vol. 11, Iss. 4, pp. 348-353
Open Access
Treatment and Prevention of HPV-Associated Skin Tumors by HPV Vaccination
Thomas Meyer, Eggert Stockfleth
Vaccines (2024) Vol. 12, Iss. 12, pp. 1439-1439
Open Access
Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model
Chelsea Sanders, Rebecca L. Matthews, Sayyed Hamid Zarkesh‐Esfahani, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4480-4487
Open Access | Times Cited: 1
Page 1

Scroll to top